SCHEMBL3750187

SCHEMBL3750187

C/C=C(/C[C@@](O)(C(=O)O)C(F)(F)F)c1ccc(Cl)c(Cl)c1OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 2/20 0.35
HSD17B10 Q99714 1/20 0.35
GAA P10253 2/20 0.33
TSHR P16473 1/20 0.33
TET2 Q6N021 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 4/20 0.31
LMNA P02545 2/20 0.31
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
GLA P06280 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
POLB P06746 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HPGD P15428 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
MEP1B Q16820 1/20 0.31
MEN1 O00255 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3750194 1.00 ALDH1A1 (0.35) ALDH1A1KDM4EHSD17B10GAATSHR
SCHEMBL3750191 1.00 ALDH1A1 (0.35) ALDH1A1KDM4EHSD17B10GAATSHR
SCHEMBL3749861 0.89 GAA (0.35) ALDH1A1GAATET2SMN1; SMN2MAPT
SCHEMBL3749863 0.89 GAA (0.35) ALDH1A1GAATET2SMN1; SMN2MAPT
SCHEMBL3749866 0.89 GAA (0.35) ALDH1A1GAATET2SMN1; SMN2MAPT
SCHEMBL1261183 0.86 ALDH1A1 (0.48) ALDH1A1KDM4EGAASMN1; SMN2MAPT
SCHEMBL1261184 0.86 ALDH1A1 (0.48) ALDH1A1KDM4EGAASMN1; SMN2MAPT
SCHEMBL3757293 0.82 ALDH1A1 (0.34) ALDH1A1KDM4EGAATET2SMN1; SMN2
SCHEMBL3757291 0.82 ALDH1A1 (0.34) ALDH1A1KDM4EGAATET2SMN1; SMN2
SCHEMBL3757297 0.82 ALDH1A1 (0.34) ALDH1A1KDM4EGAATET2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298311-A1 TETRAHYDRONAPHTHALENE DERIVATES, PROCESS FOR PREPARING THEM AND THEIR USE AS ANTIINFLAMMATORY AGENTS BERGER MARKUS 2010-11-25 US disclosed
US-20070225290-A1 Tetrahydronaphthalene derivates, processes for preparing them and their use as antiinflammatory agents BAYER SCHERING PHARMA AG (DE) 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225290-A1 Tetrahydronaphthalene derivates, processes for preparing them and their use as antiinflammatory agents TNF, IL1B, DHPS ALDH1A1 306/4885KDM4E 4319/4885HSD17B10 536/4885
US-20100298311-A1 TETRAHYDRONAPHTHALENE DERIVATES, PROCESS FOR PREPARING THEM AND THEIR USE AS ANTIINFLAMMATORY AGENTS TNF, IL1B, DHPS ALDH1A1 309/4885KDM4E 4227/4885HSD17B10 516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.